191 related articles for article (PubMed ID: 12796588)
21. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
[TBL] [Abstract][Full Text] [Related]
22. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
Bernet L; Zuñiga A; Cano R
Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
[TBL] [Abstract][Full Text] [Related]
24. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A
Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241
[TBL] [Abstract][Full Text] [Related]
25. Immunohistopathological and molecular genetic features of a case in which gastrointestinal stromal tumor recurred five times.
Inoue T; Suzuki T; Nakagawa K; Kurokawa Y; Satomi S; Moriya T; Sasano N; Sasano H
Pathol Int; 2004 Mar; 54(3):196-200. PubMed ID: 14989743
[TBL] [Abstract][Full Text] [Related]
26. Pediatric gastrointestinal stromal tumors and leiomyosarcoma.
Cypriano MS; Jenkins JJ; Pappo AS; Rao BN; Daw NC
Cancer; 2004 Jul; 101(1):39-50. PubMed ID: 15221987
[TBL] [Abstract][Full Text] [Related]
27. Prognostic analysis of rectal stromal tumors by reference of National Institutes of Health risk categories and immunohistochemical studies.
Tsai MC; Lin JW; Lin SE; Chen HH; Lee CM; Hu TH
Dis Colon Rectum; 2008 Oct; 51(10):1535-43. PubMed ID: 18633679
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in malignant gastrointestinal stromal tumors.
Muro-Cacho CA; Cantor AB; Morgan M
Ann Clin Lab Sci; 2000 Jul; 30(3):239-47. PubMed ID: 10945563
[TBL] [Abstract][Full Text] [Related]
29. [Gastrointestinal stromal tumors: a broad clinical spectrum from incidental -discovery to acute gastrointestinal bleeding].
Siewert E; Tietze L; Maintz C; Geier A; Dietrich CG; Matern S; Gartung C
Z Gastroenterol; 2004 Mar; 42(3):233-42. PubMed ID: 15022111
[TBL] [Abstract][Full Text] [Related]
30. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
[TBL] [Abstract][Full Text] [Related]
31. The utility of fine-needle aspiration in the diagnosis of gastrointestinal stromal tumors: a cytomorphologic and immunohistochemical analysis with emphasis on malignant tumors.
Elliott DD; Fanning CV; Caraway NP
Cancer; 2006 Feb; 108(1):49-55. PubMed ID: 16130141
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors of gastrointestinal stromal tumors.
Kovac D; Petrovecki M; Jasic M; Dobi-Babic R; Ivanis N; Rubinic M; Krizanac S; Jonjic N; Rizzardi C; Melato M
Anticancer Res; 2002; 22(3):1913-7. PubMed ID: 12168893
[TBL] [Abstract][Full Text] [Related]
33. [Expression and mutation of c-kit gene in gastrointestinal stromal tumor].
Ma D; Liu X; Cai Z; Xie Q
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):461-4. PubMed ID: 12485499
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
35. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
Miettinen M; Lasota J
Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
[TBL] [Abstract][Full Text] [Related]
37. PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors.
Motegi A; Sakurai S; Nakayama H; Sano T; Oyama T; Nakajima T
Pathol Int; 2005 Mar; 55(3):106-12. PubMed ID: 15743318
[TBL] [Abstract][Full Text] [Related]
38. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]